Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comprehensive assessment of musculoskeletal health in children with cystic fibrosis – randomized double blind phase IIIb
2024-517886-18-00Phase 3Authorised
- Sponsor
- Motol University Hospital
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vitamin d in cystic fibrosis (CF), disorders of bone density and structure, Vitamin D deficiency (VDD) and 1 more, sponsored by Motol University Hospital. Planned start Oct 2024; status: authorised.
02
Drugs
vitamin d
03
Conditions
cystic fibrosis (CF)disorders of bone density and structureVitamin D deficiency (VDD)Metabolic osteopathies
Beyond the preview
Go deeper on 2024-517886-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517886-18-00.